CLIN.L Share News (CLIN)

CLIN.L Information

There is currently no data for CLIN

Friday broker round-up

Fri, 05th Mar 2021 13:07

(Sharecast News) - Aggreko: Peel Hunt upgrades to hold with a target price of 880p.

QinetiQ: Berenberg reiterates buy with a target price of 375p.

Synthomer: Berenberg reiterates buy with a target price of 515p.

Vistry Group: Canaccord reiterates buy with a target price of 1,010p.

Tyman: Canaccord reiterates buy with a target price of 400p.

Entain: Deutsche Bank reiterates buy with a target price of 1,647p.

Town Centre Securities: Liberum reiterates buy with a target price of 175p.

B&M: Liberum reiterates buy with a target price of 650p.

Clinigen: Peel Hunt reiterates hold with a target price of 800p.

BT Group: Credit Suisse reiterates outperform with a target price of 200p.

Schroders: Credit Suisse reiterates neutral with a target price of 3,270p.

More News

16 Sep 2021 09:53

LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold

9 Sep 2021 16:01

UK earnings, trading statements calendar - next 7 days

2 Sep 2021 14:28

Clinigen signs UK distribution deal for Paion hospital drugs

1 Sep 2021 14:07

EXECUTIVE CHANGES: Next adds SEGRO CFO to board as non-exec director

1 Sep 2021 09:12

Allen out, Schnee in as Cliningen board chairman

(Sharecast News) - Pharmaceutical products and services company Clinigen announced on Wednesday that non-executive director and chairman-designate Elmar Schnee was becoming chairman with immediate effect.

25 Aug 2021 20:39

EXECUTIVE CHANGES: Clinigen CFO to depart, replacement search underway

25 Aug 2021 07:34

Clinigen CFO Nick Keher steps down

(Sharecast News) - Pharmaceutical group Clinigen said on Wednesday that chief financial officer Nick Keher has stepped down with immediate effect "to pursue other business interests".

5 Aug 2021 10:45

Clinigen inks partnership agreement with Eyevance Pharmaceuticals

(Sharecast News) - Pharmaceutical firm Clinigen said on Thursday that it has inked an exclusive partnership agreement with Eyevance Pharmaceuticals, a wholly-owned subsidiary of Santen Pharmaceutical.

5 Aug 2021 10:42

Clinigen partners with Eyevance to supply antifungal drug Natacyn

3 Aug 2021 15:29

EXECUTIVE CHANGES: Clinigen taps new chair; essensys hires from WeWork

21 Jul 2021 14:44

IN BRIEF: Clinigen to manage distribution of epilepsy drug Kigabeq

14 Jul 2021 13:23

Wednesday broker round-up

(Sharecast News) - Carnival: Berenberg upgrades to hold with a target price of 1,400p.

13 Jul 2021 10:43

Clinigen expects annual revenue rise in transitional year

13 Jul 2021 09:36

Clinigen ends year in line with expectations

(Sharecast News) - Pharmaceutical products and services company Clinigen updated the market on its just-ended financial year on Tuesday, saying net revenue was expected to be £455m, representing an increase of 12% on both a constant currency and organic basis.

11 Jul 2021 18:55

Sunday share tips: Clinigen, UK companies

(Sharecast News) - The Sunday Times's Sabah Meddings told readers to 'hold' shares of Clinigen amid some resurgent 'market chatter' regarding a possible bid emerging for the medicines supplier.

Latest Share Chat

CLIN.L Share News (CLIN)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up

Login to your account

Quickpicks are a member only feature

Login to your account